Droogh, D. H. M.
de Boer, M. G. J.
van Prehn, J.
Putter, H.
Bonsing, B. A.
Bosscha, K.
Bouwense, S. A. W.
Braak, J. P. B. M.
Hoogwater, F. J. H.
Lips, D. J.
Luyer, M. D. P.
Stommel, M. W. J.
Wijsman, J. H.
Besselink, M. G.
van Santvoort, H. C.
Koerkamp, B. Groot
Vahrmeijer, A. L.
Mieog, J. S. D.
,
Article History
Received: 24 July 2024
Accepted: 21 October 2024
First Online: 13 March 2025
Declarations
:
: Ethical approval for the SPARROW trial was received by the medical ethical review committee Leiden Den Haag Delft (METC LDD, identification number NL82304.058.22). Patients are only able to participate in the SPARROW trial after providing written informed consent.
: Not applicable.
: The authors declare no competing interests.